| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Silence Therapeutics Plc
13D/A
G8128Y157
|
8.0% |
8/13/2026
Event 8/12/2026
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.